Two types of vidian neurectomy show efficacy in treating allergic rhinitis and vasomotor rhinitis
Authors:
Open Access
- 8 November 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Abstract
This study aimed to evaluate the efficacies of endoscopic vidian neurectomy (VN) and highly selective vidian neurectomy (HSVN) for the treatment of allergic rhinitis (AR) and vasomotor rhinitis (VMR). All AR and VMR patients were divided into two groups, Group VN and Group HSVN. The efficacy evaluation methods were visual analog scale (VAS), rhinoconjunctivitis quality of life questionnaire (RQLQ), and medication score. The efficacy evaluations were used to assess patient rhinitis symptoms, quality of life and drug usage. The time points of follow-up period were preoperative, 3 months, 6 months, 1 year, 2 years, and 3 years post operation. By analyzing pre- and postoperative VAS, medication score and RQLQ score, the results showed that rhinitis symptoms and quality of life in both VN and HSVN groups were significantly improved at 3 years, and the rate of improvement decreased gradually with time. Post operation, there were no significant differences in VAS and medication scores between the VN and HSVN groups. With respect to RQLQ, postoperative 2 years and 3 years improvements in sleep disorders, non-nasal symptoms and eye symptoms were significantly greater in the HSVN group than in the VN group. Improvements in rhinitis symptoms and quality of life in AR and VMR were sustained by VN and HSVN until 3 years post operation, with greater quality of life improvements in the HSVN group.Keywords
All Related Versions
This publication has 21 references indexed in Scilit:
- Real world evidence of long-term benefits from allergen-specific immunotherapy (AIT)The Lancet Regional Health - Europe, 2021
- A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trialJournal of Allergy and Clinical Immunology, 2021
- Mechanisms of Allergen Immunotherapy in Allergic RhinitisCurrent Allergy and Asthma Reports, 2020
- Advances and novel developments in mechanisms of allergic inflammationAllergy, 2020
- Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revisionJournal of Allergy and Clinical Immunology, 2017
- Allergic RhinitisImmunology and Allergy Clinics of North America, 2016
- Long-term Results of Bilateral Endoscopic Vidian Neurectomy in the Management of Moderate to Severe Persistent Allergic RhinitisJAMA Otolaryngology–Head & Neck Surgery, 2012
- Endoscopic vidian neurectomyCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2012
- Allergic rhinitisThe Lancet, 2011
- Intranasal steroids or radiofrequency turbinoplasty in persistent allergic rhinitis: effects on quality of life and objective parametersEuropean Archives of Oto-Rhino-Laryngology, 2010